Abstract
As the Covid-19 pandemic (SARS-CoV-2) continues to spread globally, the influenza virus circulates in communities capable of causing significant morbidity and mortality. Further, measles outbreaks are common events as well and may trail right behind the coronavirus that causes Covid-19 and the influenza virus. Recent aerosol studies have now demonstrated that respiratory pathogens less than 5 micrometers are able to be transmitted from human-to-human capable of causing great morbidity and mortality than ever experienced with a single pandemic.
Highlights
With a possible second wave of SARS-CoV-2 that causes Covid-19 or sustained transmission this Fall and Winter, dual pandemics with seasonal influenza may occur simultaneously
As the Covid-19 pandemic (SARS-CoV-2) continues to spread globally, the influenza virus circulates in communities capable of causing significant morbidity and mortality
As the turbulent gas cloud can remain in the air for hours, and air sampling has detected both coronavirus and influenza RNA particles, the use of face coverings and face shields are recommended for source control and protecting the user [1,10,11]
Summary
With a possible second wave of SARS-CoV-2 that causes Covid-19 or sustained transmission this Fall and Winter, dual pandemics with seasonal influenza may occur simultaneously. Outbreaks of measles cases are common during the Winter months from global travel. Such a scenario is unimaginable as the influenza and measles viruses can cause great morbidity and mortality independent of each other. One thing is certain, vaccination of both the influenza and measles viruses will decrease the burden of SARS-CoV-2 infection. This paper reviews the three viruses and their burden of disease to the community via respiratory droplets and small particle aerosol transmission (Table 1). Because of the infectiousness of each viral disease, the author recommends the use of face shields with face coverings to mitigate viral respiratory disease transmission. Characteristics Transmission Route Level of Infectivity ncubation Period Risk Factors
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
